Comparison of the intraperitoneal and intravenous routes of cisplatin administration in an advanced ovarian cancer model of the rat
- 1 September 1985
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 153 (1) , 106-111
- https://doi.org/10.1016/0002-9378(85)90605-2
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- In vivo studies on the antitumor effect of cis-dichlorodiammineplatinum(II) against transplantable ovarian adenocarcinoma cells of the ratGynecologic Oncology, 1983
- Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)American Journal of Obstetrics and Gynecology, 1983
- Effect of cis-dichlorodiammineplatinum(II) on cloned ovarian adenocarcinoma cells of the rat in vitroGynecologic Oncology, 1981
- Epithelial Carcinoma of the Ovary: Current StrategiesAnnals of Internal Medicine, 1981
- PHASE-I AND PHARMACOLOGICAL STUDIES OF 5-FLUOROURACIL ADMINISTERED INTRAPERITONEALLY1980
- Cisplatin (cis-diamminedichloroplatinum II)Cancer Treatment Reviews, 1979
- PHARMACOKINETICS OF ADRIAMYCIN AND TISSUE PENETRATION IN MURINE OVARIAN-CANCER1979
- INVIVO AND INVITRO STUDIES OF EXPERIMENTAL OVARIAN ADENOCARCINOMA IN RATS1979
- PHARMACOKINETIC RATIONALE FOR PERITONEAL DRUG ADMINISTRATION IN TREATMENT OF OVARIAN CANCER1978
- High volume intraperitoneal chemotherapy (?Belly bath?) for ovarian cancerCancer Chemotherapy and Pharmacology, 1978